Phreesia Inc
NYSE:PHR
Phreesia Inc
Cost of Revenue
Phreesia Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Phreesia Inc
NYSE:PHR
|
Cost of Revenue
-$124m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cost of Revenue
-$677.3m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-23%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cost of Revenue
-$96.6m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Cost of Revenue
-$1.5B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cost of Revenue
-$53.5m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cost of Revenue
-$66.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
N/A
|
See Also
What is Phreesia Inc's Cost of Revenue?
Cost of Revenue
-124m
USD
Based on the financial report for Jan 31, 2024, Phreesia Inc's Cost of Revenue amounts to -124m USD.
What is Phreesia Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-27%
Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Phreesia Inc have been -33% over the past three years , -27% over the past five years .